This week, Holland & Knight Health Dose provides stakeholders in the health sector with a comprehensive update on legislative and regulatory developments in Washington, D.C. The topics covered include the FAA Reauthorization, the House passing the Congressional Budget Office Data Sharing Act, and the Senate Committee on Finance discussing drug shortages. Additionally, there are upcoming markups of legislation to extend telehealth waivers by the House Ways and Means Committee.
FDA officials will appear before the Energy and Commerce Subcommittee next week, while there will be hearings on administrative and regulatory burdens in healthcare. Last week’s hearings focused on cybersecurity threats, Medicaid and long-term services and supports, maternal mortality, and workforce diversity. The Medicare and Social Security Trustees have released their annual reports, along with cost-sharing FAQs from the Departments of Health and Human Services, Labor, and Treasury.
HHS has also released draft guidance for the second cycle of the Medicare Drug Price Negotiation Program. Meanwhile, the FDA has finalized its Laboratory Developed Test Final Rule. The DACA health coverage rule has been finalized as well. MACPAC appointments are also being closely watched by stakeholders in healthcare policy circles.
To learn more about these topics and stay up-to-date on other important issues affecting healthcare in Washington D.C., read this week’s Health Dose report in full.